Clinical Plenary #2

Journey Maps

Presentations

8:45 AM - 9:00 AM
Jun 24 2026
Convention Center - Hall A (General Session), Concourse Level

Weight-dependent and independent effects of semaglutide in participants with MASH: secondary analysis of the phase 3 ESSENCE trial

Philip N Newsome, MD, PhD , Abstract Presenter
Hepatitis
MASLD